Virtus Biotech Clinical Trials ETF (BBC): ETF
ETF traded on ARCX under symbol BBC. Quoted in usd.
Virtus Biotech Clinical Trials ETF
+5.62%$43.02
ARCX:BBCSector Equity
AUM $26.54M·YTD --·Yield --
ARCX:BBC$43.02+5.62%AUM $26.54MAbout BBC
This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
Largest holdings
- XNCR Xencor Inc2.26%
- KOD Kodiak Sciences Inc2.18%
- TRAX First Tracks Biotherapeutics Inc2.10%
- REPL Replimune Group Inc1.84%
- ABCL AbCellera Biologics Inc1.74%
- AMLX Amylyx Pharmaceuticals Inc1.55%
- SGP SpyGlass Pharma Inc1.51%
- VRDN Viridian Therapeutics Inc1.43%
- PRME Prime Medicine Inc1.31%
- KYMR Kymera Therapeutics Inc1.21%
Dividend History
Benchmark Comparison
Compared against
Performance Returns
Drawdown Chart
Analyst Coverage
Savings Plan Calculator
Total Invested
$70,000
Final Portfolio
$109,038
Total Return
+$39,038
(+55.8%)
Dividends Reinvested
$0
compounded into portfolio
Defaults are seeded from historical performance and trailing twelve-month yield. Past performance is not a forecast. Feel free to adjust any input to model your own assumptions.
ETF Key Metrics
AUM$26.54M
NAV$40.83
Premium/Discount+5.36%
Expense Ratio0.65%
Market Cap--
Shares Outstanding--
Inception DateDec. 16, 2014
Fund Details
IssuerVirtus
Asset ClassSector Equity
Beta--
SectorFinancial Services
DomicileUS
52-Week Range
$28.73$56.18
Current: $43.02
Volume
Volume97.14K
Avg Volume29.06K
Vol/Avg3.34x
30d
57.46K
60d
38.50K
90d
31.18K
Comparable ETFs